基本信息
浏览量:0
职业迁徙
个人简介
Clinical Trials and Research Studies
A Phase Ib/II Multicenter Open-label Modular Dose-Finding and Dose Expansion Study to Explore the Safety Tolerability and Anti-tumor Activity of Trastuzumab Deruxtecan (DS-8201a T-DXd) in Combination with other Anti-cancer Agents in Patients with Metastatic HER2-positive Breast Cancer (DESTINY-Breast07)
A Phase 2 Study of Savolitinib in Subjects with MET Amplified Metastatic Colorectal Cancer
A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
A Phase Ib/II Multicenter Open-label Modular Dose-Finding and Dose Expansion Study to Explore the Safety Tolerability and Anti-tumor Activity of Trastuzumab Deruxtecan (DS-8201a T-DXd) in Combination with other Anti-cancer Agents in Patients with Metastatic HER2-positive Breast Cancer (DESTINY-Breast07)
A Phase 2 Study of Savolitinib in Subjects with MET Amplified Metastatic Colorectal Cancer
A Phase I/II Study of M3814 and Avelumab in Combination with Hypofractionated Radiation in Patients with Advanced/Metastatic Solid Tumors and Hepatobiliary Malignancies
研究兴趣
论文共 17 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Songchuan Guo,Jonathan Melamed,Ogechukwu Eze,Christopher J. Bowman, Sunjida Ahmed,Harvey G. Moore,Cynthia A. Loomis,Adriana Heguy,Rachel I. Brody,Jonathan Serrano,K.L. Du,Jennifer Wu,
Deirdre J. Cohen,Elliot Newman,Syma Iqbal, Richard Y. Chang, Milan Potmesil,Theresa Ryan,Bernadine Donahue,Anurag Chandra,Mengling Liu, Minerva Utate,Spiros Hiotis,Leon H. Pachter,
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn